A review of thromboembolic events in hospitalized COVID-19 patients

Mostrar otras versiones (1)

CONTEXT: A higher incidence of thromboembolic disorders in COVID-19 has been reported by many clinicians worldwide. OBJECTIVE, DESIGN AND DATA SOURCES: Selected studies found in PubMed that reported thromboembolic events were included for meta-analysis using weighted fixed and random effects. Data f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontelo, Paul, Bastola, Mrigendra M., Zheng, Zhaonian, Baik, Seo Hyon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240420/
https://www.ncbi.nlm.nih.gov/pubmed/34187490
http://dx.doi.org/10.1186/s12959-021-00298-3
Descripción
Sumario:CONTEXT: A higher incidence of thromboembolic disorders in COVID-19 has been reported by many clinicians worldwide. OBJECTIVE, DESIGN AND DATA SOURCES: Selected studies found in PubMed that reported thromboembolic events were included for meta-analysis using weighted fixed and random effects. Data from 19 articles on cohort studies in patients diagnosed with COVID-19 and thromboembolic events, including thrombosis and embolism were included in this review. RESULTS: The likelihood for developing thromboembolic disorders in hospitalized COVID-19 patients was 0.28 (95% CI 0.21–0.36). CONCLUSION: This study further validates the increased risk of VTE in COVID-19 patients when compared to healthy, non-hospitalized people, and hospitalized patients. These findings will be useful to researchers and medical practitioners caring for COVID-19 patients.

Ejemplares similares